CCAD’s stroke program was designated as the Center of Excellence
for Stroke Emergencies in Abu Dhabi Island and the western
regions in October 2015 by the ministry of health, given our
unique setup of providing standard of care 24/7 for ischemic
and hemorrhagic strokes. Also, we have just successfully passed
the Joint Commission International Accreditation Survey for
stroke center designation after meeting all key metrics of a
comprehensive stroke center, to be the second accredited center in
the UAE, and only the third in the Middle East region.
Since CCAD went operational in May 2015, our average yearly
admissions for stroke patients have been rising, receiving overall
392 stroke patients in 2017 with the following breakdown: 257
ischemic strokes (of which 33 received t-PA and 46 underwent
mechanical thrombectomy), 57 subarachnoid hemorrhages and
78 intracerebral hemorrhages. Thus, our patient’s population is
predominantly cerebrovascular and young (i.e., average age for
hemorrhagic strokes is 48 years); however, we also see the entire
spectrum of neuro-ICU diseases such as subdural hematomas,
status and super refractory status epilepticus, neuromuscular
emergencies, post-operative tumor resections and meningoencephalitis.
Cleveland Clinic Abu Dhabi is composed of 14 institutes,
including the following centers of excellence: Heart &
Vascular, Neurological, Digestive Diseases, Eye, Critical
Care and Respiratory. The hospital is designated and
licensed by the Abu Dhabi Department of Health as a
research and teaching facility and is working to become
a pioneering academic medical center for the region.
Cleveland Clinic Abu Dhabi employs 330 physicians, and
around 25 percent have trained or worked at Cleveland
Clinic in the U.S.